Acute intrastriatal injection of quinolinic acid provokes long-lasting misregulation of the cytoskeleton in the striatum, cerebral cortex and hippocampus of young rats

Brain Research

Volumn 1577, Issue , 2014, Pages 1-10

  Pierozan, Paula ^a   Fernandes, Carolina Gonyalues ^a   Feireira, Fernanda ^a   Pessoa Pureur, Regina ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Cell signaling; Cytoskeleton; Intermediate filament phosphorylation; Neurotoxicity; Quinolinic acid

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLIAL FIBRILLARY ACIDIC PROTEIN; NEUROFILAMENT PROTEIN; QUINOLINIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOPROTEIN PHOSPHATASE;

ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRAIN FUNCTION; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; CYTOSKELETON; HIPPOCAMPUS; HOMEOSTASIS; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; AGING; ANIMAL; METABOLISM; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; TIME; WISTAR RAT;

RATTUS;

AGING; ANIMALS; ASTROCYTES; CEREBRAL CORTEX; CORPUS STRIATUM; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYTOSKELETON; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; HOMEOSTASIS; NEUROFILAMENT PROTEINS; PHOSPHOPROTEIN PHOSPHATASES; PHOSPHORYLATION; QUINOLINIC ACID; RATS, WISTAR; TIME FACTORS;

EID: 84925884837     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2014.06.024     Document Type: Article

References (45)

1. Albin, R.L., Young, A.B., Penney, J.B., Handelin, B., Balfour, R., Anderson, K.D., Markel, D.S., Tourtellotte, W.W., Reiner, A., 1990. Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease. N Engl. J. Med. 322, 1293-1298.
2. Beal, M.F., Kowall, N.W., Ellison, D.W., Mazurek, M.F., Swartz, K.J., Martin, J.B., 1986. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 321, 168-171.
3. Che, Y., Yu, Y.M., Han, P.L., Lee, J.K., 2001. Delayed induction of p38MAPKs in reactive astrocytes in the brain of mice after KA-induced seizure. Brain Res. Mol. Brain Res. 94, 157-165.
4. Eng, L.F., Ghirnikar, R.S., Lee, Y.L., 2000. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem. Res. 25, 1439-1451.
5. Friede, R.L., Samorajski, T., 1970. Axon caliber related to neurofilaments and microtubules in sciatic nerve fibers of rats and mice. Anat. Rec. 167, 379-387.
6. Funchal, C., de Almeida, L.M., Oliveira Loureiro, S., Vivian, L., de Lima Pelaez, P., Dall Bello Pessutto, F., Rosa, A.M., Wajner, M., Pessoa Pureur, R., 2003. In uitro phosphorylation of cytoskeletal proteins from cerebral cortex of rats. Brain Res. Brain Res. Protoc. 11, 111-118.
7. Giasson, B.I., Mushynski, W.E., 1996. Aberrant stress-induced phosphorylation of perikaryal neurofilaments. J. Biol. Chem. 271, 30404-30409.
8. Gill, S.R., Wong, P.C., Monteiro, M.J., Cleveland, D.W., 1990. Assembly properties of dominant and recessive mutations in the small mouse neurofilament (NF-L) subunit. J. Cell Biol. 111, 2005-2019.
9. Grant, P., Pant, H.C., 2000. Neurofilament protein synthesis and phosphorylation. J. Neurocytol. 29, 843-872.
10. Guidato, S., Bajaj, N.P., Miller, C.C., 1996a. Cellular phosphorylation of neurofilament heavy-chain by cyclin-dependent kinase-5 masks the epitope for monoclonal antibody N52. Neurosci. Lett. 217, 157-160.
11. Guidato, S., Tsai, L.H., Woodgett, J., Miller, C.C., 1996b. Differential cellular phosphorylation of neurofilament heavy side-arms by glycogen synthase kinase-3 and cyclin-dependent kinase-5. J. Neurochem. 66, 1698-1706.
12. Hakansson, K., Lindskog, M., Pozzi, L., Usiello, A., Fisone, G., 2004. DARPP-32 and modulation of cAMP signaling: involvement in motor control and levodopa-induced dyskinesia. Parkinsonism Relat. Disord. 10, 281-286.
13. Heimfarth, L., Loureiro, S.O., Reis, K.P., de Lima, B.O., Zamboni, F., Lacerda, S., Soska, A.K., Wild, L., daRocha, J.B., Pessoa-Pureur, R., 2012. Diphenyl ditelluride induces hypophosphorylation of intermediate filaments through modulation of DARPP-32-dependent pathways in cerebral cortex of young rats. Arch. Toxicol. 86, 217-230.
14. Heins, S., Wong, P.C., Muller, S., Goldie, K., Cleveland, D.W., Aebi, U., 1993. The rod domain of NF-L determines neurofilament architecture, whereas the end domains specify filament assembly and network formation. J. Cell Biol. 123, 1517-1533.
15. Holmgren, A., Bouhy, D., Timmerman, V., 2012. Neurofilament phosphorylation and their proline-directed kinases in health and disease. J. Peripher. Nervous Syst. 17, 365-376.
16. Inagaki, M., Gonda, Y., Nishizawa, K., Kitamura, S., Sato, C., Ando, S., Tanabe, K., Kikuchi, K., Tsuiki, S., Nishi, Y., 1990. Phosphorylation sites linked to glial filament disassembly in uitro locate in a non-alpha-helical head domain. J. Biol. Chem. 265, 4722-4729.
17. Ito, M., Natsume, A., Takeuchi, H., Shimato, S., Ohno, M., Wakabayashi, T., Yoshida, J., 2009. Type I interferon inhibits astrocytic gliosis and promotes functional recovery after spinal cord injury by deactivation of the MEK/ERK pathway. J. Neurotrauma. 26, 41-53.
18. Kayyali, U.S., Zhang, W., Yee, A.G., Seidman, J.G., Potter, H., 1997. Cytoskeletal changes in the brains of mice lacking calcineurin A alpha. J. Neurochem. 68, 1668-1678.
19. Laemmli, U.K., 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
20. Letourneau, P.C., 1996. The cytoskeleton in nerve growth cone motility and axonal pathfinding. Perspect. Dev. Neurobiol. 4, 111-123.
21. Li, B.S., Zhang, L., Takahashi, S., Ma, W., Jaffe, H., Kulkarni, A.B., Pant, H.C., 2002. Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3. EMBO J. 21, 324-333.
22. Liberto, C.M., Albrecht, P.J., Herx, L.M., Yong, V.W., Levison, S.W., 2004. Pro-regenerative properties of cytokine-activated astrocytes. J. Neurochem. 89, 1092-1100.
23. Loureiro, S.O., Romao, L., Alves, T., Fonseca, A., Heimfarth, L., Moura Neto, V., Wyse, A.T., Pessoa-Pureur, R., 2010. Homocysteine induces cytoskeletal remodeling and production of reactive oxygen species in cultured cortical astrocytes. Brain Res. 1355, 151-164.
24. Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
25. Martin, J.B., Gusella, J.F., 1986. Huntington's disease. Pathogenesis and management. N Engl. J. Med. 315, 1267-1276.
26. Middeldorp, J., Hol, E.M., 2011. GFAP in health and disease. Prog. Neurobiol. 93, 421-443.
27. Nixon, R.A., Sihag, R.K., 1991. Neurofilament phosphorylation: a new look at regulation and function. Trends Neurosci. 14, 501-506.
28. Omary, M.B., Ku, N.O., Tao, G.Z., Toivola, D.M., Liao, J., 2006. "Heads and tails" of intermediate filament phosphorylation: multiple sites and functional insights. Trends Biochem. Sci. 31, 383-394.
29. Paxinos, G., Watson, C., Pennisi, M., Topple, A., 1985. Bregma, lambda and the interaural midpoint in stereotaxic surgery with rats of different sex, strain and weight. J. Neurosci. Methods 13, 139-143.
30. Perez-De La Cruz, V., Gonzalez-Cortes, C., Galvan-Arzate, S., Medina-Campos, O.N., Perez-Severiano, F., Ali, S.F., Pedraza-Chaverri, J., Santamaria, A., 2005. Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5, 10, 15, 20-tetrakis (4-sulfonatophenyl) porphyrinate iron (III). Neuroscience 135, 463-474.
31. Pessoa-Pureur, R., Wajner, M., 2007. Cytoskeleton as a potential target in the neuropathology of maple syrup urine disease: insight from animal studies. J. Inherit. Metab. Dis. 30, 664-672.
32. Pierozan, P., Zamoner, A., Soska, A.K., Silvestrin, R.B., Loureiro, S.O., Heimfarth, L., Mello e Souza, T., Wajner, M., Pessoa-Pureur, R., 2010. Acute intrastriatal administration of quinolinic acid provokes hyperphosphorylation of cytoskeletal intermediate filament proteinsinastrocytesand neuronsofrats. Exp. Neurol. 224, 188-196.
33. Pierozan, P., Zamoner, A., Soska, A.K., de Lima, B.O., Reis, K.P., Zamboni, F., Wajner, M., Pessoa-Pureur, R., 2012. Signaling mechanisms downstream of quinolinic acid targeting the cytoskeleton of rat striatal neurons and astrocytes. Exp. Neurol. 233, 391-399.
34. Pierozan, P., Fernandes, C.G., Dutra, M.F., Pandolfo, P., Ferreira, F., de Lima, B.O., Porciuncula, L., Wajner, M., Pessoa-Pureur, R., 2014. Biochemical, histopathological and behavioral alterations caused by intrastriatal administration of quinolic acid to young rats. FEBS J..
35. Sharma, P., Veeranna, Sharma, M., Amin, N.D., Sihag, R.K., Grant, P., Ahn, N., Kulkarni, A.B., Pant, H.C., 2002. Phosphorylation of MEK1 by cdk5/p35 down-regulates the mitogen-activated protein kinase pathway. J. Biol. Chem. 277, 528-534.
36. Sihag, R.K., Nixon, R.A., 1990. Phosphorylation of the amino-terminal head domain of the middle molecular mass 145-kDa subunit of neurofilaments. Evidence for regulation by second messenger-dependent protein kinases. J. Biol. Chem. 265, 4166-4171.
37. Sihag, R.K., Inagaki, M., Yamaguchi, T., Shea, T.B., Pant, H.C., 2007. Role of phosphorylation on the structural dynamics and function of types III and IV intermediate filaments. Exp. Cell Res. 313, 2098-2109.
38. Steiner, D., Saya, D., Schallmach, E., Simonds, W.F., Vogel, Z., 2006. Adenylyl cyclase type-VIII activity is regulated by G (betagamma) subunits. Cell Signal. 18, 62-68.
39. Veeranna, Amin, Ahn, N.D., Jaffe, N.G., Winters, H., Grant, C.A., Pant, H.C., P., 1998. Mitogen-activated protein kinases (Erk1, 2) phosphorylate Lys-Ser-Pro (KSP) repeats in neurofilament proteins NF-H and NF-M. J. Neurosci. 18, 4008-4021.
40. Wang, Q., Walsh, D.M., Rowan, M.J., Selkoe, D.J., Anwyl, R., 2004. Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5. J. Neurosci. 24, 3370-3378.
41. Zamoner, A., Pierozan, P., Vidal, L.F., Lacerda, B.A., DosSantos, N.G., Vanzin, C.S., Pessoa-Pureur, R., 2008. Vimentin phosphorylation as a target of cell signaling mechanisms induced by 1alpha, 25-dihydroxyvitamin D3 in immature rat testes. Steroids 73, 1400-1408.
42. Zamoner, A., Pessoa-Pureur, R., 2011a. Nongenomic actions of thyroid hormones: every why has a wherefore. Immunol. Endocr. Metab. Agents Med. Chem. 11 (3), 165-178.
43. Zamoner, A., Pessoa-Pureur, R., 2011b. Nongenomic actions of thyroid hormones: every why has a wherefore. Immunol. Endocr. Metab. Agents Med. Chem. 11 (3), 165-178.
44. Zanatta, L., Goulart, P.B., Goncalves, R., Pierozan, P., Winkelmann-Duarte, E.C., Woehl, V.M., Pessoa-Pureur, R., Silva, F.R., Zamoner, A., 2012. 1alpha, 25-dihydroxyvitamin D(3) mechanism of action: modulation of L-type calcium channels leading to calcium uptake and intermediate filament phosphorylation in cerebral cortex of young rats. Biochim. Biophys. Acta 1823, 1708-1719.
45. Zhu, Q., Couillard-Despres, S., Julien, J.P., 1997. Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments. Exp. Neurol. 148, 299-316.